1. Home
  2. ENTA
  3. ENTA News

Latest Enanta Pharmaceuticals Inc. (ENTA) News on April 2, 2025

Enanta Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
ENTA

Business Wire

16 days ago

Enanta Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium
ENTA

Business Wire

21 days ago

Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium

With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns
ENTA

Simply Wall St.

2 months ago

With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns

President of Enanta Pharmaceuticals Picks Up 5.9% More Stock
ENTA

Simply Wall St.

2 months ago

President of Enanta Pharmaceuticals Picks Up 5.9% More Stock

Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade
ENTA

Zacks

2 months ago

Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade

ENTA

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 02/13/2025

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates
ENTA

Zacks

2 months ago

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

ENTA

Associated Press Finance

2 months ago

Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024
ENTA

Business Wire

2 months ago

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024

Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial
ENTA

Clinical Trials Arena

2 months ago

Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial

Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last?
ENTA

Zacks

2 months ago

Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last?

Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ENTA

Business Wire

3 months ago

Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ENTA

MT Newswires

3 months ago

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

ENTA

MT Newswires

3 months ago

Top Midday Decliners

ENTA

MT Newswires

3 months ago

Enanta Pharmaceuticals to Appeal Court Ruling on Patent Infringement Case Against Pfizer

ENTA

MT Newswires

3 months ago

HC Wainwright Adjusts Price Target on Enanta Pharmaceuticals to $18 From $27, Maintains Buy Rating

Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit
ENTA

Business Wire

3 months ago

Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit

Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last?
ENTA

Zacks

3 months ago

Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last?

Enanta’s zelicapavir shows promise in paediatric respiratory syncytial virus trial
ENTA

Clinical Trials Arena

4 months ago

Enanta’s zelicapavir shows promise in paediatric respiratory syncytial virus trial

ENTA

MT Newswires

4 months ago

Enanta Pharma Reports Positive Phase 2 Results for Zelicapavir as Treatment of Respiratory Syncytial Virus

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)
ENTA

Business Wire

4 months ago

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)

Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)
ENTA

Business Wire

4 months ago

Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)

Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility
ENTA

TipRanks

4 months ago

Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility

ENTA

MT Newswires

4 months ago

Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $14 From $16, Maintains Perform Rating

ENTA

MT Newswires

4 months ago

Enanta Pharmaceuticals Fiscal Q4 Net Loss Widens, Revenue Declines

Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates
ENTA

Zacks

4 months ago

Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates

ENTA

Associated Press Finance

4 months ago

Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024
ENTA

Business Wire

4 months ago

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024

The past three years for Enanta Pharmaceuticals (NASDAQ:ENTA) investors has not been profitable
ENTA

Simply Wall St.

5 months ago

The past three years for Enanta Pharmaceuticals (NASDAQ:ENTA) investors has not been profitable

Enanta Pharmaceuticals (ENTA): Promising Clinical Stage Biotech with Robust Pipeline
ENTA

Insider Monkey

5 months ago

Enanta Pharmaceuticals (ENTA): Promising Clinical Stage Biotech with Robust Pipeline

Millennium Management LLC's Strategic Acquisition of Enanta Pharmaceuticals Shares
ENTA

GuruFocus.com

5 months ago

Millennium Management LLC's Strategic Acquisition of Enanta Pharmaceuticals Shares

Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains?
ENTA

Zacks

6 months ago

Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains?

J&J builds case for Talvey; FDA panel questions PD-1 drugs for certain cancers
ENTA

BioPharma Dive

6 months ago

J&J builds case for Talvey; FDA panel questions PD-1 drugs for certain cancers

ENTA

MT Newswires

6 months ago

Enanta Pharmaceuticals Says Phase 2a Trial of Potential RSV Treatment Meets Endpoints

Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
ENTA

Business Wire

6 months ago

Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)

Enanta Pharmaceuticals to Participate in Investor Conferences in September
ENTA

Business Wire

7 months ago

Enanta Pharmaceuticals to Participate in Investor Conferences in September

Enanta Pharmaceuticals, Inc. (ENTA): Caligan Partners’ Top Holding Right Now?
ENTA

Insider Monkey

8 months ago

Enanta Pharmaceuticals, Inc. (ENTA): Caligan Partners’ Top Holding Right Now?

Enanta Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
ENTA

Simply Wall St.

8 months ago

Enanta Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates
ENTA

Zacks

8 months ago

Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates

ENTA

Associated Press Finance

8 months ago

Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
ENTA

Business Wire

8 months ago

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter

Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?
ENTA

Zacks

9 months ago

Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?

Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
ENTA

Business Wire

10 months ago

Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference

Enanta Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
ENTA

Simply Wall St.

a year ago

Enanta Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

ENTA

MT Newswires

a year ago

JMP Securities Adjusts Enanta Pharmaceuticals Price Target to $22 From $23, Maintains Market Outperform Rating

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
ENTA

Insider Monkey

a year ago

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript

ENTA

Thomson Reuters StreetEvents

a year ago

Q2 2024 Enanta Pharmaceuticals Inc Earnings Call

Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference

ENTA

GuruFocus.com

a year ago

Enanta Pharmaceuticals Inc (ENTA) (Q2 2024) Earnings Call Transcript Highlights: Navigating ...

Enanta Pharmaceuticals Reports Fiscal Q2 Results: A Closer Look Against Analyst Expectations
ENTA

GuruFocus.com

a year ago

Enanta Pharmaceuticals Reports Fiscal Q2 Results: A Closer Look Against Analyst Expectations

Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
ENTA

Zacks

a year ago

Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates

ENTA

Associated Press Finance

a year ago

Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET

Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss
ENTA

Simply Wall St.

a year ago

Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss

Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer

Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024

Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
ENTA

Simply Wall St.

a year ago

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
ENTA

Insider Monkey

a year ago

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript

ENTA

Thomson Reuters StreetEvents

a year ago

Q1 2024 Enanta Pharmaceuticals Inc Earnings Call

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
ENTA

Zacks

a year ago

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates

Enanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ...
ENTA

GuruFocus.com

a year ago

Enanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ...

ENTA

Associated Press Finance

a year ago

Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET

Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Rainbow Realty Group Announces Launch of Fund IV: Capitalizing on a Moment in Time
ENTA

PR Newswire

a year ago

Rainbow Realty Group Announces Launch of Fund IV: Capitalizing on a Moment in Time

ENTA

Reuters

a year ago

UPDATE 2-Novavax announces fresh round of layoffs to rein in costs

Novavax announces fresh round of layoffs to rein in costs
ENTA

Reuters

a year ago

Novavax announces fresh round of layoffs to rein in costs

Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023

Fubo Makes Strategic Investment in BKFC, Will Stream BKFC 57 Live Event on February 2
ENTA

Business Wire

a year ago

Fubo Makes Strategic Investment in BKFC, Will Stream BKFC 57 Live Event on February 2

Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets
ENTA

Business Wire

a year ago

Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets

ENTA

Business Wire

a year ago

ClearBridge MLP Funds Announce Proposed Mergers and Updates for Tender Offers

Earnings Preview: BrightSphere Investment Group (BSIG) Q4 Earnings Expected to Decline
ENTA

Zacks

a year ago

Earnings Preview: BrightSphere Investment Group (BSIG) Q4 Earnings Expected to Decline

ENTA

Associated Press Finance

a year ago

LSI: Fiscal Q2 Earnings Snapshot

LSI Industries Reports Fiscal 2024 Second Quarter Results and Declares Quarterly Cash Dividend
ENTA

Business Wire

a year ago

LSI Industries Reports Fiscal 2024 Second Quarter Results and Declares Quarterly Cash Dividend

Citizens & Northern Corp's Dividend Analysis
ENTA

GuruFocus.com

a year ago

Citizens & Northern Corp's Dividend Analysis

McEwen (MUX) Loses -13.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ENTA

Zacks

a year ago

McEwen (MUX) Loses -13.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

National News Literacy Week 2024: Spotlight on local news
ENTA

PR Newswire

a year ago

National News Literacy Week 2024: Spotlight on local news

ENTA

Business Wire

a year ago

Franklin Templeton Fund Adviser, LLC Announces Distributions for the Month of February 2024

Compass Diversified Promises Faster Growth to Investors
ENTA

Barrons.com

a year ago

Compass Diversified Promises Faster Growth to Investors

Getty Realty Corp. Announces 2023 Dividend Tax Treatment
ENTA

GlobeNewswire

a year ago

Getty Realty Corp. Announces 2023 Dividend Tax Treatment

3 REITs with Yields over 6%
ENTA

Benzinga

a year ago

3 REITs with Yields over 6%

Compass Diversified Announces Partnership with The Honey Pot Company
ENTA

GlobeNewswire

a year ago

Compass Diversified Announces Partnership with The Honey Pot Company

Nabors Industries (NYSE:NBR) Shareholders Will Want The ROCE Trajectory To Continue
ENTA

Simply Wall St.

a year ago

Nabors Industries (NYSE:NBR) Shareholders Will Want The ROCE Trajectory To Continue

The Top Healthcare Stocks to Buy With $100
ENTA

Motley Fool

a year ago

The Top Healthcare Stocks to Buy With $100

DocGo Rejects Short Seller Report and Releases Preliminary 2024 Revenue Guidance
ENTA

Business Wire

a year ago

DocGo Rejects Short Seller Report and Releases Preliminary 2024 Revenue Guidance

Option Care Health Selects Palantir’s Artificial Intelligence Platform for Enterprise-Wide Digital Transformation
ENTA

GlobeNewswire

a year ago

Option Care Health Selects Palantir’s Artificial Intelligence Platform for Enterprise-Wide Digital Transformation

Allogene (ALLO) Down 20% on Strategic Changes in Pipeline
ENTA

Zacks

a year ago

Allogene (ALLO) Down 20% on Strategic Changes in Pipeline

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?
ENTA

Zacks

a year ago

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
ENTA

Zacks

a year ago

Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?

Why WW International Stock Just Dropped 11%
ENTA

Motley Fool

a year ago

Why WW International Stock Just Dropped 11%

The Best-Performing REITs Of 2023
ENTA

Benzinga

a year ago

The Best-Performing REITs Of 2023

Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference

Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ENTA

Business Wire

a year ago

Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Real Estate Rebound: Top 3 REITs for Robust Returns in 2024
ENTA

InvestorPlace

a year ago

Real Estate Rebound: Top 3 REITs for Robust Returns in 2024

2023’s most notable deals in trucking
ENTA

FreightWaves

a year ago

2023’s most notable deals in trucking

Should You Be Worried About Daseke, Inc.'s (NASDAQ:DSKE) 9.1% Return On Equity?
ENTA

Simply Wall St.

a year ago

Should You Be Worried About Daseke, Inc.'s (NASDAQ:DSKE) 9.1% Return On Equity?

Skeena Closes C$10.7 Million Flow-Through Financing
ENTA

ACCESSWIRE

a year ago

Skeena Closes C$10.7 Million Flow-Through Financing

Share on Social Networks: